ALPS Advisors’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,454
| Closed | -$271K | – | 1025 |
|
|
2024
Q4 | $271K | Sell |
9,454
-200
| -2% | -$5.73K | ﹤0.01% | 948 |
|
|
2024
Q3 | $373K | Buy |
9,654
+439
| +5% | +$17K | ﹤0.01% | 726 |
|
|
2024
Q2 | $297K | Sell |
9,215
-55
| -0.6% | -$1.77K | ﹤0.01% | 851 |
|
|
2024
Q1 | $360K | Buy |
+9,270
| New | +$360K | ﹤0.01% | 767 |
|
|
2019
Q3 | – | Sell |
-22,320
| Closed | -$294K | – | 855 |
|
|
2019
Q2 | $294K | Sell |
22,320
-1,176
| -5% | -$15.5K | ﹤0.01% | 844 |
|
|
2019
Q1 | $356K | Buy |
+23,496
| New | +$356K | ﹤0.01% | 852 |
|